{"id":"https://openalex.org/W56513856","doi":"https://doi.org/10.1182/blood.v122.21.850.850","title":"Final Results Of Phase II Study Of Lenalidomide Plus Rituximab-CHOP21 In Elderly Untreated Diffuse Large B-Cell Lymphoma Focusing On The Analysis Of Cell Of Origin: REAL07 Trial Of The Fondazione Italiana Linfomi","display_name":"Final Results Of Phase II Study Of Lenalidomide Plus Rituximab-CHOP21 In Elderly Untreated Diffuse Large B-Cell Lymphoma Focusing On The Analysis Of Cell Of Origin: REAL07 Trial Of The Fondazione Italiana Linfomi","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W56513856","doi":"https://doi.org/10.1182/blood.v122.21.850.850","mag":"56513856"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.850.850","doi":"https://doi.org/10.1182/blood.v122.21.850.850","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.850.850","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054623894","display_name":"Annalisa Chiappella","orcid":"https://orcid.org/0000-0002-2977-0098","observed_orcids":["https://orcid.org/0000-0002-2977-0098"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annalisa Chiappella","raw_affiliation_strings":["On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063909411","display_name":"Silvia Franceschetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Silvia Franceschetti","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020978640","display_name":"Alessia Castellino","orcid":"https://orcid.org/0000-0002-1922-9054","observed_orcids":["https://orcid.org/0000-0002-1922-9054"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessia Castellino","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016794322","display_name":"Angelo Michele Carella","orcid":"https://orcid.org/0000-0002-4967-4204","observed_orcids":["https://orcid.org/0000-0002-4967-4204","https://orcid.org/0000-0002-6710-7393"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Angelo Michele Carella","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027869659","display_name":"Ileana Baldi","orcid":"https://orcid.org/0000-0002-8578-9164","observed_orcids":["https://orcid.org/0000-0002-8578-9164"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Ileana Baldi","raw_affiliation_strings":["Department of Cardiac, Thoracic and Vascular Sciences, University, Unit of Biostatistics, Epidemiology and Public Health, Padova, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiac, Thoracic and Vascular Sciences, University, Unit of Biostatistics, Epidemiology and Public Health, Padova, Italy,","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074069337","display_name":"Manuela Zanni","orcid":"https://orcid.org/0000-0001-9638-9062","observed_orcids":["https://orcid.org/0000-0001-9638-9062","https://orcid.org/0009-0007-7695-5603"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Manuela Zanni","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071466957","display_name":"Anna Marina Liberati","orcid":"https://orcid.org/0000-0002-3686-3188","observed_orcids":["https://orcid.org/0000-0002-3686-3188"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Marina Liberati","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081879832","display_name":"Michele Spina","orcid":"https://orcid.org/0000-0001-6576-8182","observed_orcids":["https://orcid.org/0000-0001-6576-8182"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele Spina","raw_affiliation_strings":["On the behalf of the Fondazione Italiana Linfomi, Aviano, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"On the behalf of the Fondazione Italiana Linfomi, Aviano, Italy,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076236981","display_name":"Alessandra Tucci","orcid":"https://orcid.org/0000-0003-3052-7463","observed_orcids":["https://orcid.org/0000-0003-3052-7463"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessandra Tucci","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069053301","display_name":"Vincenzo Pavone","orcid":"https://orcid.org/0000-0003-1712-2744","observed_orcids":["https://orcid.org/0000-0003-1712-2744"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vincenzo Pavone","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111088110","display_name":"Anna Lia Molinari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Anna Lia Molinari","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091882595","display_name":"Pier Luigi Zinzani","orcid":"https://orcid.org/0000-0002-2112-2651","observed_orcids":["https://orcid.org/0000-0002-2112-2651"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pier Luigi Zinzani","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076114231","display_name":"Flavia Salvi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Flavia Salvi","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024430820","display_name":"Marcello Gaudiano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Marcello Gaudiano","raw_affiliation_strings":["University, Department of Pathology and Center for Experimental Research and medical Studies (CERMS), Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University, Department of Pathology and Center for Experimental Research and medical Studies (CERMS), Torino, Italy,","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045339988","display_name":"Pier Paolo Fattori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Pier Paolo Fattori","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071128692","display_name":"Alfonso Zaccaria","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alfonso Zaccaria","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070003191","display_name":"Barbara Botto","orcid":"https://orcid.org/0009-0005-7514-6172","observed_orcids":["https://orcid.org/0009-0005-7514-6172"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Barbara Botto","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110464585","display_name":"Angela Giovanna Congiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Angela Congiu","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046704362","display_name":"Giovannino Ciccone","orcid":"https://orcid.org/0000-0001-7644-9574","observed_orcids":["https://orcid.org/0000-0001-7644-9574"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giovannino Ciccone","raw_affiliation_strings":["Hematology, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076353357","display_name":"Marco Ladetto","orcid":"https://orcid.org/0000-0002-8283-2681","observed_orcids":["https://orcid.org/0000-0002-8283-2681"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Ladetto","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046049357","display_name":"Martin H. Dreyling","orcid":"https://orcid.org/0000-0002-0358-5249","observed_orcids":["https://orcid.org/0000-0002-0358-5249"]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Dreyling","raw_affiliation_strings":["Klinikum Der Universitaet Muenchen-Campus Grosshadern, Munich, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinikum Der Universitaet Muenchen-Campus Grosshadern, Munich, Germany,","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041745367","display_name":"Gianluca Ga\u00efdano","orcid":"https://orcid.org/0000-0002-4681-0151","observed_orcids":["https://orcid.org/0000-0002-4681-0151"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluca Gaidano","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006640724","display_name":"Giorgio Inghirami","orcid":"https://orcid.org/0000-0001-5566-0864","observed_orcids":["https://orcid.org/0000-0001-5566-0864","https://orcid.org/0000-0002-5298-6516"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giorgio Inghirami","raw_affiliation_strings":["Department of Pathology and Center for Experimental Research and Medical Studies (CeRMS), University of Turin, Turin, Italy, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Center for Experimental Research and Medical Studies (CeRMS), University of Turin, Turin, Italy, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101631020","display_name":"Giuseppe Rossi","orcid":"https://orcid.org/0000-0001-8377-2898","observed_orcids":["https://orcid.org/0000-0001-8377-2898"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giuseppe Rossi","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000403848","display_name":"Umberto Vitolo","orcid":"https://orcid.org/0000-0001-7772-2747","observed_orcids":["https://orcid.org/0000-0001-7772-2747"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Umberto Vitolo","raw_affiliation_strings":["Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology 2, Citt\u00e0 della Salute e della Scienza Hospital and University, On the behalf of the Fondazione Italiana Linfomi, Torino, Italy,","institution_ids":["https://openalex.org/I4210086903"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5006640724","https://openalex.org/A5016794322","https://openalex.org/A5020978640","https://openalex.org/A5024430820","https://openalex.org/A5027869659","https://openalex.org/A5045339988","https://openalex.org/A5046704362","https://openalex.org/A5063909411","https://openalex.org/A5070003191","https://openalex.org/A5071128692","https://openalex.org/A5076114231","https://openalex.org/A5076236981","https://openalex.org/A5101631020","https://openalex.org/A5110464585","https://openalex.org/A5111088110"],"corresponding_institution_ids":["https://openalex.org/I138689650","https://openalex.org/I4210086903","https://openalex.org/I55143463"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.9031,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.72246556,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"122","issue":"21","first_page":"850","last_page":"850"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9399999976158142},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9729999899864197},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9150000214576721},{"id":"https://openalex.org/keywords/previously-untreated-lymphoma","display_name":"previously untreated lymphoma","score":0.8059999942779541},{"id":"https://openalex.org/keywords/cell-of-origin","display_name":"cell of origin","score":0.9120000004768372},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7319999933242798},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9649999737739563},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.7009999752044678},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.5270000100135803},{"id":"https://openalex.org/keywords/hans-algorithm","display_name":"Hans algorithm","score":0.48899999260902405},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.4790000021457672},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.5329999923706055},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.32100000977516174},{"id":"https://openalex.org/keywords/geriatric-assessment","display_name":"geriatric assessment","score":0.3370000123977661}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.9173858165740967},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7377254366874695},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.69574373960495},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6893997192382812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6134613752365112},{"id":"https://openalex.org/C2778476033","wikidata":"https://www.wikidata.org/wiki/Q1667625","display_name":"International Prognostic Index","level":4,"score":0.5332357883453369},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.481916218996048},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4581226110458374},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4384550452232361},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4286535382270813},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3785688281059265},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.34909534454345703},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.29312145709991455},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.17094698548316956}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.850.850","doi":"https://doi.org/10.1182/blood.v122.21.850.850","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.850.850","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2135860817","https://openalex.org/W2566347093","https://openalex.org/W2980030407","https://openalex.org/W3120715707","https://openalex.org/W2591350172","https://openalex.org/W3097118178","https://openalex.org/W2982852619","https://openalex.org/W3128028170","https://openalex.org/W2605767476","https://openalex.org/W4200168211"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"The":[2,89],"standard":[3,119],"treatment":[4],"for":[5,190,277,310,319,327,436,471,484],"elderly":[6,63],"untreated":[7,64,162,555],"diffuse":[8],"large":[9],"B-cell":[10],"lymphoma":[11],"(DLBCL)":[12],"is":[13,454,529,567],"RCHOP21,":[14],"however":[15],"up":[16],"to":[17,74,102,116,134,147,188,209,223,449],"40%":[18],"of":[19,58,106,111,118,139,250,283,357,365,372,379,383,390,414,431,441,474,501],"patients":[20,227,268],"experienced":[21],"failures.":[22],"Lenalidomide":[23],"showed":[24],"activity":[25],"in":[26,31,34,62,82,113,388,428,478,511,521,532,537,554,563],"heavily":[27],"pretreated":[28],"DLBCL":[29,65,415,566],"and":[30,33,66,87,133,212,262,273,300,318,326,335,346,412,464,486,492,513],"vivo":[32],"vitro":[35],"data":[36,542],"demonstrated":[37,54],"a":[38,280,472,498,544],"synergism":[39],"with":[40,84,137,206,213,340],"rituximab.":[41],"In":[42,526],"the":[43,56,78,158,248,353,373,380,391,439],"phase":[44,90,546],"I":[45],"trial":[46,92,549],"REAL07":[47,93],"(Chiappella":[48],"et":[49],"al,":[50],"Haematol":[51],"2013),":[52],"FIL":[53],"that":[55],"association":[57],"LRCHOP21":[59,114,528,551],"was":[60,94,144,204,254,288,295,303,313,368,386,400,416,446,506,516],"feasible":[61],"identified":[67],"15":[68,182],"mg":[69,183,370],"lenalidomide":[70,184,366,562],"from":[71,185],"day":[72,75,186],"1":[73,187],"14":[76,189],"as":[77],"maximum":[79],"tolerated":[80],"dose":[81,364,382],"combination":[83],"RCHOP21.":[85,120],"Patients":[86],"methods.":[88],"II":[91],"designed":[95],"based":[96],"on":[97],"Simon's":[98],"two":[99],"stage":[100,167,239],"design":[101],"demonstrate":[103],"an":[104],"improvement":[105],"overall":[107,127],"response":[108],"rate":[109],"(ORR)":[110],"15%":[112],"compared":[115],"70%":[117,304],"Secondary":[121],"endpoints":[122],"were":[123,195,228,259,338,361,426,434,468,488],"progression-free":[124],"survival":[125,128,131],"(PFS),":[126],"(OS),":[129],"event-free":[130],"(EFS)":[132],"correlate":[135],"outcome":[136],"cell":[138],"origin":[140],"(COO)":[141],"profile.":[142],"Response":[143],"evaluated":[145],"according":[146,208,448],"2007":[148],"Cheson":[149],"criteria.":[150],"Inclusion":[151],"criteria":[152],"were:":[153,232],"age":[154,234],"60-80":[155],"FIT":[156],"at":[157,173,376],"comprehensive":[159],"geriatric":[160],"assessment;":[161],"CD20+":[163],"DLBCL;":[164],"Ann":[165],"Arbor":[166],"II/III/IV;":[168],"international":[169],"prognostic":[170],"index":[171],"(IPI)":[172],"low-intermediate/intermediate-high/high":[174],"(LI/IH/H)":[175],"risk.":[176],"Treatment":[177],"plan":[178],"was:":[179],"RCHOP21":[180,392,398,553],"plus":[181],"6":[191,251],"courses.":[192,393],"All":[193,405],"cases":[194,407],"centrally":[196],"reviewed":[197],"by":[198,573],"expert":[199],"pathologist;":[200],"COO":[201,419,444],"profile":[202,216],"analysis":[203,445,453],"conducted":[205],"immunohistochemistry":[207,450],"Hans'":[210],"algorithm":[211],"gene":[214],"expression":[215],"(DASL":[217],"assay).":[218],"Results.":[219],"From":[220],"April":[221],"2010":[222],"May":[224],"2011,":[225],"49":[226,406],"enrolled.":[229],"Clinical":[230,456],"characteristics":[231,457],"median":[233,281,363,499],"69":[235],"years":[236],"(range":[237,403],"61-80);":[238],"III/IV":[240],"43":[241],"(88%),":[242],"IPI":[243,311,320,328,476],"IH/H":[244],"30":[245],"(61%).":[246],"At":[247,279,438,497],"end":[249],"LRCHOP21,":[252,358],"ORR":[253,483],"92%.":[255],"Complete":[256],"remissions":[257],"(CR)":[258],"42":[260],"(86%)":[261],"partial":[263],"remission":[264],"3":[265,267],"(6%);":[266],"(6%)":[269],"did":[270],"not":[271],"respond":[272],"one":[274],"(2%)":[275],"died":[276],"homicide.":[278],"follow-up":[282,500],"28":[284,502],"months,":[285,503],"2-year":[286,293,308,504],"OS":[287],"92%":[289],"(95%":[290,297,305,315,323,331,508,518],"CI:":[291,298,306,316,324,332,509,519],"79-97),":[292],"PFS":[294,309,505,515],"80%":[296],"64-89)":[299],"2-years":[301,514],"EFS":[302],"55-81);":[307],"LI":[312],"89%":[314],"62-97)":[317],"IH":[321],"76%":[322],"47-90)":[325],"H":[329,475],"72%":[330],"36-90).":[333],"Hematological":[334],"extra-hematological":[336,344],"toxicities":[337],"mild,":[339],"no":[341,347],"grade":[342],"IV":[343],"events":[345],"toxic":[348],"deaths":[349],"during":[350],"treatment.":[351],"Of":[352],"294":[354],"planned":[355,374,381],"courses":[356,399],"277":[359],"(94%)":[360],"administered;":[362],"delivered":[367],"1185":[369],"(94%":[371],"dose);":[375],"least":[377],"90%":[378],"each":[384],"drug":[385,570],"administered":[387],"91%":[389],"Median":[394],"interval":[395],"time":[396,440],"between":[397,458],"21":[401],"days":[402],"19-48).":[404],"underwent":[408],"central":[409],"pathology":[410],"review":[411],"diagnosis":[413],"confirmed.":[417],"Regarding":[418],"analysis,":[420],"tissue":[421],"block":[422],"or":[423],"stained":[424],"slides":[425],"collected":[427],"40/49":[429],"(82%),":[430],"which":[432],"32":[433],"adequate":[435],"analysis.":[437],"this":[442],"abstract,":[443],"reported":[447],"data;":[451],"DASL":[452],"ongoing.":[455],"germinal":[459],"center":[460],"(GCB,":[461],"16":[462],"patients)":[463,467],"non-GCB":[465,479,487,538,556],"(16":[466],"superimposable,":[469],"excepted":[470],"majority":[473],"risk":[477,534],"group":[480],"(p":[481],"0.067).":[482],"GCB":[485],"88%":[489,493],"(CR":[490,494],"81%)":[491],"88%),":[495],"respectively.":[496],"71%":[507],"40-88)":[510],"GCB-group":[512],"81%":[517],"51-93)":[520],"non-GCB-group":[522],"(Figure":[523],"1).":[524],"Conclusions.":[525],"conclusion,":[527],"effective,":[530],"also":[531],"poor":[533],"patients,":[535],"namely":[536],"subgroup.":[539],"These":[540],"encouraging":[541],"warrant":[543],"future":[545],"III":[547],"randomized":[548],"comparing":[550],"vs.":[552],"DLBCL.":[557],"Disclosures:":[558],"Off":[559],"Label":[560],"Use:":[561],"first":[564],"line":[565],"off":[568],"lable.":[569],"provided":[571],"free":[572],"Celgene.":[574],"Vitolo:Roche:":[575],"Speakers":[576,579,582],"Bureau;":[577,580],"Celgene:":[578],"Takeda:":[581],"Bureau.":[583]},"counts_by_year":[{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}